{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:24:45Z","timestamp":1784255085793,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K07035"],"award-info":[{"award-number":["20K07035"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejphar.2021.174714","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T02:35:08Z","timestamp":1640140508000},"page":"174714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells"],"prefix":"10.1016","volume":"916","author":[{"given":"Kazuya","family":"Sumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-1944","authenticated-orcid":false,"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiko","family":"Mashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Funakoshi-Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174714_bib1","first-page":"1","article-title":"Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives","volume":"8","author":"Anagnostou","year":"2017","journal-title":"Blood Lymphat. Cancer"},{"key":"10.1016\/j.ejphar.2021.174714_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/Imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174714_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040795","article-title":"Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif","volume":"7","author":"Beck","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174714_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood-2005-01-0241","article-title":"Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation","volume":"106","author":"Chou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.174714_bib5","first-page":"1","article-title":"Acute lymphoblastic leukemia","author":"Conter","year":"2004","journal-title":"Orphanet Encyclopedia"},{"key":"10.1016\/j.ejphar.2021.174714_bib6","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood-2007-03-080838","article-title":"Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors","volume":"110","author":"Cortes","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.174714_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","article-title":"Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin","volume":"268","author":"Fenteany","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174714_bib8","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.cellsig.2012.06.014","article-title":"Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway","volume":"24","author":"Funakoshi-Tago","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2021.174714_bib9","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.1038\/s41598-020-76445-z","article-title":"Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells","volume":"10","author":"Funakoshi-Tago","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174714_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.intimp.2014.02.035","article-title":"Effect of chemical modification on the ability of pyrrolidinium fullerene to induce apoptosis of cells transformed by JAK2 V617F mutant","volume":"20","author":"Funakoshi-Tago","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.174714_bib11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174714_bib12","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"Goussetis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.174714_bib13","first-page":"100","article-title":"Signaling networks associated with BCR-ABL-dependent transformation","volume":"16","author":"Hazlehurst","year":"2009","journal-title":"Canc. Control"},{"key":"10.1016\/j.ejphar.2021.174714_bib14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus Imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Hochhaus","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174714_bib15","doi-asserted-by":"crossref","first-page":"41525","DOI":"10.1038\/srep41525","article-title":"Oridonin triggers chaperon-mediated proteasomal degradation of BCR-ABL in leukemia","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174714_bib16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bmcl.2014.01.045","article-title":"A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox","volume":"24","author":"Kamogawa","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.174714_bib17","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174714_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.leukres.2012.11.003","article-title":"Imatinib and Nilotinib inhibit Bcr-Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phox","volume":"37","author":"Landry","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2021.174714_bib19","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-15-1544","article-title":"Naturally occurring isothiocyanates exert anticancer effects by inhibiting deubiquitinating enzymes","volume":"75","author":"Lawson","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2021.174714_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bcp.2013.10.014","article-title":"Andrographolide downregulates the v-Src and Bcr-Abl oncoproteins and induces Hsp90 cleavage in the ROS-dependent suppression of cancer malignancy","volume":"87","author":"Liu","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174714_bib21","doi-asserted-by":"crossref","first-page":"21683","DOI":"10.1073\/pnas.1016311108","article-title":"As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia","volume":"107","author":"Mao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174714_bib22","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/j.bmcl.2003.09.040","article-title":"Antibacterial and antiproliferative activity of cationic fullerene derivatives","volume":"13","author":"Mashino","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.174714_bib23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0968-0896(02)00610-7","article-title":"Respiratory chain inhibition by fullerene derivatives: hydrogen peroxide production caused by fullerene derivatives and a respiratory chain system","volume":"11","author":"Mashino","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174714_bib24","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/leu.2009.49","article-title":"Bcr-Abl-mediated redox regulation of the PI3K\/AKT pathway","volume":"23","author":"Naughton","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2021.174714_bib25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.leu.2404236","article-title":"Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(u)-LMC GROUP)","volume":"20","author":"Nicolini","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2021.174714_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3109\/10715760903273849","article-title":"Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells","volume":"43","author":"Nishizawa","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2021.174714_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"O'Hare","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2021.174714_bib28","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1038\/sj.onc.1206094","article-title":"BCR\/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations","volume":"21","author":"Pane","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174714_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.redox.2017.07.010","article-title":"Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells","volume":"13","author":"Park","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2021.174714_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-015-0407-0","article-title":"BCR\/ABL1 and BCR are under the transcriptional control of the MYC oncogene","volume":"14","author":"Sharma","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2021.174714_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/0008-5472.CAN-10-1066","article-title":"BCR\/ABL stimulates WRN to promote survival and genomic instability","volume":"71","author":"Slupianek","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2021.174714_bib32","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"Sattler","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174714_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.05.018","article-title":"Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation","volume":"154","author":"Uchihara","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174714_bib34","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","article-title":"Jak2 is involved in c-Myc induction by Bcr-Abl","volume":"21","author":"Xie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174714_bib35","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.2147\/IJN.S212045","article-title":"Synthesis and antitumor activity of novel pyridinium fullerene derivatives","volume":"14","author":"Yasuno","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2021.174714_bib36","doi-asserted-by":"crossref","first-page":"17707","DOI":"10.1016\/S0021-9258(19)47429-2","article-title":"Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells","volume":"266","author":"Yoshimori","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174714_bib37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/leu.2008.74","article-title":"Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921008700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921008700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:16:29Z","timestamp":1762143389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921008700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":37,"alternative-id":["S0014299921008700"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174714","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174714"}}